Literature DB >> 6092651

Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart.

J G Dobson, J Schrader.   

Abstract

Isolated guinea pig hearts were used to determine whether an extracellular (interstitial) or intracellular pool of myocardial adenosine is most important in attenuating the catecholamine-induced enhancement of cardiac contractile state and glycogenolysis. Isoproterenol (2 X 10(-8) M) stimulation of hypoxic (30% O2) perfused hearts produced a marked elevation in tissue and effluent perfusate adenosine levels that were greater than the increases observed with the isoproterenol stimulation of oxygenated hearts (95% O2). In the isoproterenol stimulated hypoxic hearts nitrobenzylthioinosine (NBMPR), a potent inhibitor of adenosine cellular transport, further increased tissue adenosine content and markedly decreased the perfusate level of the nucleoside. Assuming that perfusate levels of adenosine correlate directly with extracellular levels, NBMPR was used as a tool to increase the intracellular and decrease the extracellular content of the nucleoside. When compared to responses in oxygenated hearts, hypoxia reduced the isoproterenol-produced increase in myocardial cyclic AMP content, cyclic AMP-dependent protein kinase activity and contractility but enhanced the increase in glycogen phosphorylase alpha formation. NBMPR completely prevented the reduction of the isoproterenol-induced cyclic AMP and cyclic AMP-dependent protein kinase responses but only partially prevented the attenuation of the contractile response. The increase in phosphorylase alpha formation in the hypoxic isoproterenol stimulated hearts was not influenced by NBMPR. The results suggest that an increase in extracellular adenosine is more influential than an elevation of intracellular adenosine in attenuating beta-adrenoceptor-elicited increases in myocardial cyclic AMP content, cyclic AMP-dependent protein kinase activity and contractile state.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092651     DOI: 10.1016/s0022-2828(84)80005-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

1.  Analysis of the atypical characteristics of adenosine receptors mediating negative inotropic and chronotropic responses of guinea-pig isolated atria and papillary muscles.

Authors:  N M Gardner; K J Broadley
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism.

Authors:  B B Lerman; R C Wesley; J P DiMarco; D E Haines; L Belardinelli
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

3.  On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic crossclamping entraps intracellular adenosine and protects against reperfusion injury: role of adenosine A1 receptor.

Authors:  Anwar Saad Abd-Elfattah; Mai Ding; Michael E Jessen; Andrew S Wechsler
Journal:  J Thorac Cardiovasc Surg       Date:  2012-02-09       Impact factor: 5.209

4.  Endogenous adenosine is an autacoid feedback inhibitor of chloride transport in the shark rectal gland.

Authors:  G G Kelley; O S Aassar; J N Forrest
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

5.  How does dipyridamole elevate extracellular adenosine concentration? Predictions from a three-compartment model of adenosine formation and inactivation.

Authors:  A C Newby
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

6.  Endogenous adenosine improves work rate to oxygen consumption ratio in catecholamine stimulated isovolumic rat heart.

Authors:  J Headrick; R J Willis
Journal:  Pflugers Arch       Date:  1989-02       Impact factor: 3.657

7.  Antagonism between (-)-N6-phenylisopropyladenosine and the calcium channel facilitator Bay K 8644, on guinea-pig isolated atria.

Authors:  L Caparrotta; G Fassina; G Froldi; R Poja
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

8.  Ranolazine may exert its beneficial effects by increasing myocardial adenosine levels.

Authors:  D Elizabeth Le; Catherine M Davis; Kevin Wei; Yan Zhao; Zhiping Cao; Matthew Nugent; Kristin L Lyon Scott; Lijuan Liu; Shanthi Nagarajan; Nabil J Alkayed; Sanjiv Kaul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-13       Impact factor: 4.733

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.